Pharma

Your Article Summary

See Latest Articles

Repligen Announces Conference Call of First Quarter Fiscal Year 2010 Results Thursday, August
Repligen, 07/31/09

Repligen Corporation announced that the Company President and Chief Executive Officer, Walter C. Herlihy, Ph.D., will host a conference call and webcast on Thursday, August 2009 to report first quarter fiscal year 2010 financial results and to provide a quarterly update of the Company.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas Wednesday, December 9
Repligen, 12/09/09

Allos Therapeutics' FOLOTYN Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Treated with Stem Cell Transplant
Allos Therapeutics, 12/08/09

ARIAD Presents Positive Clinical Proof-of-Concept Data on AP24534 in Drug-Resistant Hematological Cancers at ASH Annual Meeting
ARIAD Pharmaceuticals, 12/08/09

 See all of Conferences/Meetings

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Report: Acquisition Activity Down
HealthDataManagement, 12/08/09

Genzyme Provides Update on Cerezyme Supply and 2009 Financial Information
Genzyme, 12/07/09

Medtronic Board Approves Third Quarter Cash Dividend for Fiscal Year 2010
Medtronic, 12/04/09

 See all of Financial Reports